148 related articles for article (PubMed ID: 25151293)
1. Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.
Allott EH; Tse CK; Olshan AF; Carey LA; Moorman PG; Troester MA
Breast Cancer Res Treat; 2014 Sep; 147(2):415-21. PubMed ID: 25151293
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
3. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
6. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.
Clarke CA; Canchola AJ; Moy LM; Neuhausen SL; Chung NT; Lacey JV; Bernstein L
Breast Cancer Res; 2017 May; 19(1):52. PubMed ID: 28460643
[TBL] [Abstract][Full Text] [Related]
7. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD.
Gallicchio L; Visvanathan K; Burke A; Hoffman SC; Helzlsouer KJ
Int J Cancer; 2007 Jul; 121(1):211-15. PubMed ID: 17330846
[TBL] [Abstract][Full Text] [Related]
9. NSAID use and survival after breast cancer diagnosis in post-menopausal women.
Blair CK; Sweeney C; Anderson KE; Folsom AR
Breast Cancer Res Treat; 2007 Jan; 101(2):191-7. PubMed ID: 16823508
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings.
Kirsh VA; Kreiger N; Cotterchio M; Sloan M; Theis B
Am J Epidemiol; 2007 Sep; 166(6):709-16. PubMed ID: 17660454
[TBL] [Abstract][Full Text] [Related]
11. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.
Sherman ME; Vierkant RA; Masters M; Radisky DC; Winham SJ; Degnim AC; Vachon CM; Patel AV; Teras LR
Cancer Prev Res (Phila); 2023 Mar; 16(3):175-184. PubMed ID: 36596665
[TBL] [Abstract][Full Text] [Related]
12. Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.
Jayasekara H; MacInnis RJ; Chamberlain JA; Dite GS; Leoce NM; Dowty JG; Bickerstaffe A; Win AK; Milne RL; Giles GG; Terry MB; Eccles DM; Southey MC; Hopper JL
Int J Cancer; 2019 Dec; 145(12):3207-3217. PubMed ID: 30771221
[TBL] [Abstract][Full Text] [Related]
13. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited.
Zhang Y; Coogan PF; Palmer JR; Strom BL; Rosenberg L
Am J Epidemiol; 2005 Jul; 162(2):165-70. PubMed ID: 15972932
[TBL] [Abstract][Full Text] [Related]
14. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.
Dierssen-Sotos T; Gómez-Acebo I; de Pedro M; Pérez-Gómez B; Servitja S; Moreno V; Amiano P; Fernandez-Villa T; Barricarte A; Tardon A; Diaz-Santos M; Peiro-Perez R; Marcos-Gragera R; Lope V; Gracia-Lavedan E; Alonso MH; Michelena-Echeveste MJ; Garcia-Palomo A; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
BMC Cancer; 2016 Aug; 16(1):660. PubMed ID: 27542890
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
16. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.
Coghill AE; Newcomb PA; Campbell PT; Burnett-Hartman AN; Adams SV; Poole EM; Potter JD; Ulrich CM
Gut; 2011 Apr; 60(4):491-8. PubMed ID: 21051449
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
O'Brien KM; Cole SR; Tse CK; Perou CM; Carey LA; Foulkes WD; Dressler LG; Geradts J; Millikan RC
Clin Cancer Res; 2010 Dec; 16(24):6100-10. PubMed ID: 21169259
[TBL] [Abstract][Full Text] [Related]
19. The effect of NSAIDs exposure on breast cancer risk in female patients with autoimmune diseases.
Hung CH; Lin YC; Chang YH; Lin YC; Huang HY; Yeh WJ; Wu TY; Hou MF
Eur J Cancer Prev; 2019 Sep; 28(5):428-434. PubMed ID: 30339576
[TBL] [Abstract][Full Text] [Related]
20. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Dunnwald LK; Rossing MA; Li CI
Breast Cancer Res; 2007; 9(1):R6. PubMed ID: 17239243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
